The survival analysis revealed that a high expression of CCND1 was a poor prognosis in HNSC and PAAD, while a high expression of CCND1 was a good prognosis in KIRC, STAD, THCA, and UCEC (Figures 9, 10). The gene discussed is CCND1; the disease is pancreatic adenocarcinoma.